Vertex Pharmaceuticals Incorporated

10/19/2019 | Press release | Distributed by Public on 10/19/2019 18:47

Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and Older, and ORKAMBI®[...]